Although there was an increase in the median percentages of IL-17+ and IL-17+IFN-γ+CD4+ T cells after treatment of active TB (TB6 vs TB0) these differences were not statistically significant (Figures 2C,D). This evidence concerns the gene IL17A and tuberculosis.